Onaiza Cadoret-Manier
Director/Board Member at ARDELYX, INC.
Net worth: 2 M $ as of 2024-03-30
Profile
Onaiza Cadoret-Manier is an Independent Director at Ardelyx, Inc. since 2020 and at Ventyx Biosciences, Inc. since 2023.
Previously, she held the position of Vice President-Respiratory Franchise at Genentech, Inc. from 2011 to 2018.
She also served as the Chief Commercial Officer at GRAIL LLC and Grail Biosciences from 2018 to 2019.
In addition, she was the EVP, Chief Product Strategy & Operations Officer at Ionis Pharmaceuticals, Inc. from 2020 to 2024.
Ms. Cadoret-Manier completed her undergraduate degree at Queens College in 1985 and obtained an MBA from The University of Chicago in 1989.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-02-01 | 35,825 ( 0.02% ) | 2 M $ | 2024-03-30 | |
ARDELYX, INC.
0.05% | 2023-06-14 | 110,150 ( 0.05% ) | 804 095 $ | 2024-03-30 |
VENTYX BIOSCIENCES, INC.
-.--% | 2024-01-20 | 0 ( -.--% ) | - $ | 2024-03-30 |
Onaiza Cadoret-Manier active positions
| Companies | Position | Start |
|---|---|---|
| ARDELYX, INC. | Director/Board Member | 2020-03-11 |
| VENTYX BIOSCIENCES, INC. | Director/Board Member | 2023-01-10 |
Former positions of Onaiza Cadoret-Manier
| Companies | Position | End |
|---|---|---|
| IONIS PHARMACEUTICALS, INC. | Chief Operating Officer | 2024-03-14 |
GRAIL LLC
 GRAIL LLC Electronic Equipment/InstrumentsElectronic Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Corporate Officer/Principal | 2019-04-30 |
| Grail Biosciences | Corporate Officer/Principal | 2018-12-31 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | 2018-04-30 |
Training of Onaiza Cadoret-Manier
| Queens College | Undergraduate Degree |
| The University of Chicago | Masters Business Admin |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| IONIS PHARMACEUTICALS, INC. | Health Technology |
| ARDELYX, INC. | Health Technology |
| VENTYX BIOSCIENCES, INC. | Health Technology |
| Private companies | 3 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
GRAIL LLC
GRAIL LLC Electronic Equipment/InstrumentsElectronic Technology GRAIL LLC is a healthcare company. It engages in the development of a technology for early detection of cancer. The company was founded by Jeffrey T. Huber, William H. Rastetter, and Mostafa Ronaghi on September 11, 2015 and is headquartered in Menlo Park, CA. | Electronic Technology |
| Grail Biosciences |
- Stock Market
- Insiders
- Onaiza Cadoret-Manier
